Compound Q&A
What is the market or research trend for Belinostat (CAS: 414864-00-9)?
Answer
The market and research trend for Belinostat (CAS: 414864-00-9) is focused on its use as an antineoplastic agent, particularly in the treatment of hematologic malignancies and solid tumors. Recent trends indicate a growing interest in its combination therapies and the exploration of its mechanism of action. Research is also expanding into the development of more potent and selective HDAC inhibitors to improve efficacy and reduce side effects.
About
CAS No
414864-00-9
English Name
Belinostat(PXD-101)
Molecular Formula
C15H14N2O4S
Molecular Weight
318.3 g/mol
SMILES
C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO
InChIKey
NCNRHFGMJRPRSK-MDZDMXLPSA-N
Last Updated: 2025-09-08 18:31
